{
    "medicine_id": "4519a5154c7e903fd071dea85f5621570f264b89",
    "platform_id": "DB08930",
    "metadata": {
        "name": "Dovato 52 6 mg Tablet film coated",
        "composition": "52 6 mg Dolutegravir",
        "clinical_particulars": {
            "therapeutic_indications": "Dolutegravir is indicated in combination with other antiretroviral agents for the treatment of patients with HIV 1 infection that comply with the characteristics of being adults or children aged 12 years and older and present at least a weight of 40 kg A7520 The FDA combination therapy approval of dolutegravir and rilpivirine is indicated for adults with HIV 1 infections whose virus is currently suppressed 50 copies ml on a stable regimen for at least six months without history of treatment failure and no known substitutions associated to resistance to any of the two components of the therapy L1031",
            "contraindications": {
                "disease": "There was no significant increases in drug related neoplasms or in genotoxic effects or in mating or fertility effects A31345",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "HIV 1 infected subjects on dolutegravir monotherapy demonstrated rapid and dose dependent reduction of antiviral activity with declines of HIV 1 RNA copies per ml The antiviral response was maintained for 3 to 4 days after the last dose A7516 The sustained response obtained in clinical trials indicates that dolutegravir has a tight binding and longer dissociative half life providing it a high barrier to resistance A31343 The combination therapy ripivirine and dolutegravir presented the same viral suppression found in previous three drug therapies without integrase strand transfer inhibitor mutations or rilpivirine resistance L1033",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The serum concentration of Dofetilide can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium acetate"
                    },
                    {
                        "drugbank-id": "DB00326",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium glucoheptonate"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium chloride"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium gluconate"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium Phosphate"
                    },
                    {
                        "drugbank-id": "DB13231",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium lactate"
                    },
                    {
                        "drugbank-id": "DB13365",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium lactate gluconate"
                    },
                    {
                        "drugbank-id": "DB13590",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium pangamate"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The serum concentration of Metformin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00139",
                        "description": "The excretion of Succinic acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00155",
                        "description": "The excretion of Citrulline can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "The excretion of Oseltamivir can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The excretion of Cefotiam can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "The excretion of Piperacillin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00345",
                        "description": "The excretion of Aminohippuric acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The excretion of Trifluridine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The excretion of Allopurinol can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The excretion of Cefdinir can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The excretion of Cephalexin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "The excretion of Valaciclovir can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The excretion of Levocarnitine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00650",
                        "description": "The excretion of Leucovorin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00693",
                        "description": "The excretion of Fluorescein can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00770",
                        "description": "The excretion of Alprostadil can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The excretion of Acyclovir can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The excretion of Cefaclor can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The excretion of Quinapril can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The excretion of Bumetanide can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00917",
                        "description": "The excretion of Dinoprostone can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01053",
                        "description": "The excretion of Benzylpenicillin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The excretion of Rosuvastatin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The excretion of Cefazolin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The excretion of Ceftizoxime can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The excretion of Cefacetrile can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The excretion of Ceftibuten can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01606",
                        "description": "The excretion of Tazobactam can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB02527",
                        "description": "The excretion of Cyclic adenosine monophosphate can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The excretion of Cholic Acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB03553",
                        "description": "The excretion of Glutaric Acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB03902",
                        "description": "The excretion of Oxalic Acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "The excretion of Doripenem can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The excretion of Saxagliptin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08846",
                        "description": "The excretion of Ellagic acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The excretion of Cefaloridine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09060",
                        "description": "The excretion of Avibactam can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The excretion of Eluxadoline can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12243",
                        "description": "The excretion of Edaravone can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12377",
                        "description": "The excretion of Relebactam can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The excretion of Hydrochlorothiazide can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The excretion of Famotidine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The excretion of Conjugated estrogens can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The excretion of Indomethacin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The excretion of Methotrexate can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The excretion of Hydrocortisone can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The excretion of Tetracycline can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The excretion of Ranitidine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The excretion of Captopril can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The excretion of Tenofovir alafenamide can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The excretion of Tenofovir disoproxil can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The excretion of Taurocholic acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The excretion of Cimetidine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The excretion of Estrone can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The excretion of Oxytetracycline can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The excretion of Polythiazide can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The excretion of Prednisolone phosphate can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "Magnesium oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "Aluminum hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Magnesium hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Magnesium carbonate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13249",
                        "description": "Magnesium silicate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13280",
                        "description": "Aluminium acetoacetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "Magnesium peroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13626",
                        "description": "Aluminium glycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13829",
                        "description": "Calcium silicate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14517",
                        "description": "Aluminium phosphate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Testosterone propionate"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Fosamprenavir"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "Zinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB02165",
                        "description": "Zinc trihydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04249",
                        "description": "Zinc Substituted Heme C can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09221",
                        "description": "Polaprezinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09321",
                        "description": "Zinc oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09322",
                        "description": "Zinc sulfate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "Zinc citrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11175",
                        "description": "Zinc picolinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11248",
                        "description": "Zinc gluconate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14479",
                        "description": "Acetylcysteine zinc can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14485",
                        "description": "Zinc ascorbate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14487",
                        "description": "Zinc acetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14493",
                        "description": "Zinc glycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14533",
                        "description": "Zinc chloride can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14548",
                        "description": "Zinc sulfate unspecified form can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14532",
                        "description": "Zinc cation can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Sucralfate"
                    },
                    {
                        "drugbank-id": "DB00516",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Bentoquatam"
                    },
                    {
                        "drugbank-id": "DB01575",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Kaolin"
                    },
                    {
                        "drugbank-id": "DB08938",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Magaldrate"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Potassium alum"
                    },
                    {
                        "drugbank-id": "DB11081",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum chloride"
                    },
                    {
                        "drugbank-id": "DB11239",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum sulfate"
                    },
                    {
                        "drugbank-id": "DB11306",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Bentonite"
                    },
                    {
                        "drugbank-id": "DB13322",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Hydrotalcite"
                    },
                    {
                        "drugbank-id": "DB13650",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Aloglutamol"
                    },
                    {
                        "drugbank-id": "DB13654",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Montmorillonite"
                    },
                    {
                        "drugbank-id": "DB00893",
                        "description": "Iron Dextran can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01592",
                        "description": "Iron can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06783",
                        "description": "Prussian blue can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09146",
                        "description": "Iron sucrose can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09147",
                        "description": "Ferric pyrophosphate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09501",
                        "description": "Ferric ammonium citrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09507",
                        "description": "Ferumoxsil can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09508",
                        "description": "Ferumoxides can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11171",
                        "description": "Ferric sulfate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11210",
                        "description": "Ferrous bisglycinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11417",
                        "description": "Gleptoferron can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11576",
                        "description": "Ferric oxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB12821",
                        "description": "Perflubutane can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13257",
                        "description": "Ferrous sulfate anhydrous can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13381",
                        "description": "Sodium feredetate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13423",
                        "description": "Ferric hydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13949",
                        "description": "Ferric cation can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14488",
                        "description": "Ferrous gluconate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14489",
                        "description": "Ferrous succinate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14491",
                        "description": "Ferrous fumarate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14520",
                        "description": "Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB14695",
                        "description": "Ferric oxyhydroxide can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB15598",
                        "description": "Ferric maltol can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB09343",
                        "description": "The excretion of Tipiracil can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Dolutegravir can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Pravastatin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01051",
                        "description": "Novobiocin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "Hesperetin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "Dexamethasone may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Dasatinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02115",
                        "description": "Daidzin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03467",
                        "description": "Naringenin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "Vandetanib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "Vismodegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "Teriflunomide may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "Dabrafenib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "Palbociclib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "Olaparib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Baricitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "Glasdegib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "Avatrombopag may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "Gilteritinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "Brigatinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Estradiol dienanthate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "Medical Cannabis may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "Nabiximols may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "Fedratinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "Istradefylline may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "Caffeine may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Gefitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "Beclomethasone dipropionate may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "Imatinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Buprenorphine may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Sunitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "Genistein may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "Quercetin may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "Cabazitaxel may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "Alectinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "Abemaciclib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "Dovitinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "Ripretinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "Fostemsavir may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Pralsetinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "Clofazimine may decrease the excretion rate of Dolutegravir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Vardenafil"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "The excretion of Varenicline can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The serum concentration of Solriamfetol can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The serum concentration of Prazosin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The serum concentration of Choline salicylate can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00122",
                        "description": "The serum concentration of Choline can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The serum concentration of Norepinephrine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "The serum concentration of Pramipexole can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The serum concentration of Epinephrine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The serum concentration of Amantadine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The serum concentration of Dopamine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The serum concentration of Memantine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB05381",
                        "description": "The serum concentration of Histamine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The serum concentration of Agmatine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Selenium"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB14490",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Ferrous ascorbate"
                    },
                    {
                        "drugbank-id": "DB14519",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum cation"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The serum concentration of Dolutegravir can be decreased when it is combined with Calcium cation"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The excretion of Pemetrexed can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The excretion of Mercaptopurine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The excretion of Valproic acid can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB04540",
                        "description": "Cholesterol may increase the excretion rate of Dolutegravir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the excretion rate of Dolutegravir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "The excretion of Cidofovir can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The excretion of Stavudine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "The excretion of Adefovir dipivoxil can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "The excretion of Didanosine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00943",
                        "description": "The excretion of Zalcitabine can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The excretion of Grepafloxacin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The excretion of Levofloxacin can be decreased when combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00173",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Adenine"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Indinavir"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Flurbiprofen"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Sodium aurothiomalate"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB09298",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Silibinin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Pexidartinib"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB13609",
                        "description": "The metabolism of Dolutegravir can be decreased when combined with Umifenovir"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain tice live antigen can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain connaught live antigen can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The therapeutic efficacy of Bacillus calmette guerin substrain danish 1331 live antigen can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The therapeutic efficacy of Human adenovirus e serotype 4 strain cl 68578 antigen can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Live attenuated can be decreased when used in combination with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The serum concentration of Vincristine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The serum concentration of Bortezomib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Gemcitabine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Imipramine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Trimipramine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Nortriptyline can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Cobimetinib"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Silodosin"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Ceritinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The serum concentration of Lenvatinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Talinolol can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The serum concentration of Tenofovir can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tolvaptan"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Idelalisib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Lefamulin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The serum concentration of Eliglustat can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The serum concentration of Cisplatin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The serum concentration of Oxaliplatin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The serum concentration of Procainamide can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "The serum concentration of Dalfampridine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The serum concentration of Clofarabine can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Darolutamide"
                    },
                    {
                        "drugbank-id": "DB11644",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Tafamidis"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Dolutegravir may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Capmatinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}